Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Author

Niven Narain 1 posts 0 comments

Dr. Niven R. Narain is Co-Founder, President & CEO of BERG, LLC, a Boston-based biopharma driving next-generation drug development by combining patient-driven biology and Bayesian AI. Narain is a member of the NASA/Gene Lab Steering Committee, Advisor to DoD leadership on breast and prostate cancer and forged strategic partners with industry, academia, and US and UK governments.